Liquidia Q1 Earnings Call Highlights
Liquidia (NASDAQ:LQDA) reported sharply higher first-quarter 2026 sales and profitability as executives said the launch of YUTREPIA continued to gain traction in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. On the company’s earnings call, Chi
MarketBeat ·